Chatap Guy, Giraud Karine, Delay Virginie, Cassereau Catherine, Bastuji-Garin Sylvie, Vincent Jean-Pierre, Cornu Henri-Pierre
Service de Médecine Interne Gériatrique, Hôpital René Muret, Sevran, France.
Therapie. 2008 Sep-Oct;63(5):393-401. doi: 10.2515/therapie:2008058. Epub 2009 Jan 21.
Objective. To determinate, for older subjects, specific factors of imbalance of the oral anticoagulant treatments. Method. We conducted an epidemiological and analytical case-control study, during 18 months, in 2 geriatrics centers. Each patient with excessive anticoagulation (INR>4.5) was matched with 2 controls under anticoagulant, whom the INR (international normalized ratio) had stayed in the therapeutic range. Results. One-hundred fifty nine subjects (53 cases and 106 controls) were included. Haemorrhagic complications has been observed in 19.2% of cases, versus 3.9% of the controls. Some medicines frequently prescribed to the old subjects were correlated at a risk of excessive anticoagulation: amiodarone (9.4% versus 0, p<0.004), acetaminophen (18.9% versus 0.9%, p<0.001), tramadol (5.6% versus 0, p<0.04), ofloxacine (11.3% versus 1.9%, p<0.001), and lactulose (11.3% versus 0, p<0.001). Furthermore, several acute states increase the risk of excessive INR to the old subjects: fever (p<0.001), malnutrition (p<0.001), dehydration (p=0.006), and acute diarrhea (p<0.001). Conclusion. Some specific geriatric factors raised may destabilize treatments by anticoagulants.
目的。确定老年受试者口服抗凝治疗失衡的特定因素。方法。我们在2个老年医学中心进行了一项为期18个月的流行病学和分析性病例对照研究。每例抗凝过度(国际标准化比值[INR]>4.5)的患者与2例接受抗凝治疗且INR(国际标准化比值)维持在治疗范围内的对照进行匹配。结果。纳入了159名受试者(53例病例和106例对照)。19.2%的病例观察到出血并发症,而对照为3.9%。一些经常开给老年受试者的药物与抗凝过度风险相关:胺碘酮(9.4%对0,p<0.004)、对乙酰氨基酚(18.9%对0.9%,p<0.001)、曲马多(5.6%对0,p<0.04)、氧氟沙星(11.3%对1.9%,p<0.001)和乳果糖(11.3%对0,p<0.001)。此外,几种急性状态会增加老年受试者INR过高的风险:发热(p<0.001)、营养不良(p<0.001)、脱水(p=0.006)和急性腹泻(p<0.001)。结论。一些特定的老年因素可能会破坏抗凝治疗的稳定性。